These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6465620)

  • 41. Haemorheology and cerebrovascular disease: multifunctional approach with pentoxifylline.
    Müller R; Lehrach F
    Curr Med Res Opin; 1981; 7(4):253-63. PubMed ID: 7014106
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Blood rheology in chronic arterial occlusive disease as influenced by vasodilators (author's transl)].
    Störmer B; Kleinschmidt F; Loose D; Kremer K
    Dtsch Med Wochenschr; 1978 Apr; 103(16):694-8. PubMed ID: 639718
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Phenytoin and acute mountain sickness on Mount Everest.
    Wohns RN; Colpitts M; Clement T; Karuza A; Blackett WB; Foutch R; Larson E
    Am J Med; 1986 Jan; 80(1):32-6. PubMed ID: 3510539
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Improvement of the flow properties of blood: a new therapeutical approach in occlusive arterial disease.
    Ehrly AM
    Angiology; 1976 Mar; 27(3):188-96. PubMed ID: 1078314
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Clinical evaluation of the effects of pentoxifylline in patients with chronic peripheral circulatory disorders].
    Strano A; Davì G; Novo S; Avellone G; Pinto A
    Ric Clin Lab; 1981; 11 Suppl 1():303-11. PubMed ID: 7188117
    [No Abstract]   [Full Text] [Related]  

  • 46. Hemorheologic treatment of cerebral reversible ischemic episodes with pentoxifylline--a prospective study.
    Ott E; Körner E; Lechner H
    Angiology; 1988 Jun; 39(6):520-5. PubMed ID: 3377272
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Amelioration of the symptoms of acute mountain sickness by staging and acetazolamide.
    Evans WO; Robinson SM; Horstman DH; Jackson RE; Weiskopf RB
    Aviat Space Environ Med; 1976 May; 47(5):512-6. PubMed ID: 1275841
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Correction of disorders of peripheral circulation with trental in children in the postoperative period].
    Doletskiĭ AS; Dallakian NO; Aksel'rov AM; Nazarova NB; Sokolova VA
    Anesteziol Reanimatol; 1985; (4):56-8. PubMed ID: 4061952
    [No Abstract]   [Full Text] [Related]  

  • 49. Vascular atherosclerotic disease: evaluation of the whole-blood filterability and red cell membrane microrheological pattern after intravenous administration of a single dose of pentoxifylline.
    Caimi G; Serra A; Francavilla G; Romano A; Catania A; Sarno A
    Curr Med Res Opin; 1990; 12(4):263-7. PubMed ID: 2076624
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of flunarizine and pentoxifylline on walking distance and blood rheology in claudication.
    Perhoniemi V; Salmenkivi K; Sundberg S; Johnsson R; Gordin A
    Angiology; 1984 Jun; 35(6):366-72. PubMed ID: 6375469
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pentoxifylline treatment in patients with occlusive peripheral arterial disease. Circulatory changes and effects on prostaglandin synthesis.
    Poggesi L; Scarti L; Boddi M; Masotti G; Serneri GG
    Angiology; 1985 Sep; 36(9):628-37. PubMed ID: 3901827
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pulmonary vascular reactivity and hemorheology in patients with chronic cor pulmonale: responses to pentoxifylline at rest and during exercise.
    Sturani C; Palareti G; Poggi M; Schiavina M; Torricelli P; Papiris S; Coccheri S; Gunella G
    Ric Clin Lab; 1986; 16(4):569-78. PubMed ID: 3576055
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Studies of the clinical pharmacology and therapeutic efficacy of pentoxifylline in peripheral obstructive arterial disease.
    Di Perri T; Carandente O; Vittoria A; Guerrini M; Messa GL
    Angiology; 1984 Jul; 35(7):427-35. PubMed ID: 6540539
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Use of the preparation trental in artificial circulation].
    Soboleva ER; Samsonova NN
    Anesteziol Reanimatol; 1986; (5):64-6. PubMed ID: 3492944
    [No Abstract]   [Full Text] [Related]  

  • 55. Effect of pentoxifylline on microvascular blood flow velocity.
    Ohshima N; Sato M
    Angiology; 1981 Nov; 32(11):752-63. PubMed ID: 7325410
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effect of pentoxifylline on red cell deformability in cerebrovascular accidents.
    Martin P; Vives P
    Curr Med Res Opin; 1980; 6(8):518-22. PubMed ID: 6248293
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Improvement of blood viscosity in sickle-cell anaemia by pentoxifylline (author's transl)].
    Keller F; Leonhardt H
    Dtsch Med Wochenschr; 1980 Jun; 105(25):898-900. PubMed ID: 7408665
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Erythrocyte filterability and treatment with pentoxifylline].
    Valentini M; Sciannameo F; Francucci M; Tockner M; Sassano L; Allegra A
    Ric Clin Lab; 1983; 13 Suppl 3():455-8. PubMed ID: 6673029
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Red cell flexibility and platelet aggregation in patients with chronic obstructive vascular disease (COAD) and study of therapeutic approaches.
    Ambrus JL; Ambrus CM; Taheri SA; Gastpar H; Reddington MM; Taheri P; Kahn EA; Schattman GL; Dean LS; Moore RH
    Angiology; 1984 Jul; 35(7):418-26. PubMed ID: 6540538
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Blood pressure, intraocular pressure, and retinal vessels after high altitude mountain exposure.
    Brinchmann-Hansen O; Myhre K
    Aviat Space Environ Med; 1989 Oct; 60(10 Pt 1):970-6. PubMed ID: 2803164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.